Encyclopedia of Virology: New Research (6 Volume Set)

This six volume set presents important research on virology. Some of the topics addressed include:
· the fundamentals of Zika virus
· preparation for pandemic diseases
· West Nile virus
· the management of the spread of Ebola virus disease
· human papillomaviruses
· viral hemorrhagic fevers
· the treatment of avian influenza virus
· bronchiolitis

 

Volume 1
Chapter 1. Zika Virus: An Introduction
Chapter 2. Zika Virus Infection: A New Thread for Pregnancy
Chapter 3. Distribution of Zika Virus Infection Specific IgG in Western Province of Zambia: A Population-Based Study
Chapter 4. Correlates of Zika Virus Infection Specific IgG in North-Western Province of Zambia: Results from a Population-Based Cross-Sectional Study
Chapter 5. Zika Virus: Basics About the Disease
Chapter 6. Zika Virus in Latin America and the Caribbean: U. S. Policy Considerations
Chapter 7. Zika Response Funding: Request and Congressional Action
Chapter 8. Emerging Infectious Diseases: Preliminary Observations on the Zika Virus Outbreak
Chapter 9. Discovery of Anti-Zika Drugs Using in Silico Pharmacophore Modeling
Chapter 10. Zika Virus: The Quest for Vaccines
Chapter 11. Quantitative Nucleic Acid Sequence Comparison Methods in the Characterization and Surveillance of Emerging Pathogens: A Study of Flavivirus Strains Including the Zika Virus
Chapter 12. Data-Driven Strategies to Model and Mitigate the Threat of Zika
Chapter 13. Hearing Loss Due to Congenital Zika Virus Infection
Chapter 14. Emerging Infectious Diseases: Actions Needed to Address the Challenges of Responding to Zika Virus Disease Outbreaks
Chapter 15. Testimony of Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Hearing on ''Examining the U. S. Public Health Response to the Zika Virus''
Chapter 16. Testimony of Joseph M. Conlon, Technical Advisor, American Mosquito Control Association. Hearing on ''Examining the U. S. Public Health Response to the Zika Virus''
Chapter 17. Statement of Dr. Luciana Borio, Acting Chief Scientist, U. S. Food and Drug Administration. Hearing on ''Examining the U. S. Public Health Response to the Zika Virus''
Chapter 18. Testimony of Dr. Thomas R. Frieden, Director, Centers for Disease Control and Prevention. Hearing on ''Examining the U. S. Public Health Response to the Zika Virus''
Chapter 19. Testimony of Lawrence O. Gostin, Faculty Director, O'Neill Institute for National and Global Health Law. Hearing on ''Examining the U. S. Public Health Response to the Zika Virus''
Chapter 20. Testimony of Dr. Kacey C. Ernst, Associate Professor, University of Arizona. Hearing on ''Science of Zika: The DNA of an Epidemic''
Chapter 21. Testimony of Dr. Daniel Neafsey, Associate Director, Genomic Center for Infectious Disease, Broad Institute of MIT and Harvard. Hearing on ''Science of Zika: The DNA of an Epidemic''
Chapter 22. Statement of Hadyn Parry, Chief Executive Officer, Oxitec. Hearing on ''Science of Zika: The DNA of an Epidemic''
Volume 2
Chapter 23. Strategies for Preventing and Controlling Avian Influenza Outbreaks in Poultry
Chapter 24. Chinese Herbal Medicine: An Ancient Weapon on Emerging SARS
Chapter 25. Severe Acute Respiratory Syndrome: Lessons in Planning for Pandemic Diseases
Chapter 26. Genetic Evolution of Avian Influenza Virus of Subtype H9N2 in Dubai
Chapter 27. South American Arenaviral Hemorrhagic Fevers
Chapter 28. Selected Viral Hemorrhagic Fevers – A Lot of Questions, Few Answers
Chapter 29. The Characteristics of Bats and Fruit Bats as Reservoirs of Selected Infectious Diseases with Emphasis on Viral Hemorrhagic Fevers
Chapter 30. Viral Hemorrhagic Fevers – Yesterday and Today
Chapter 31. Japanese Encephalitis - Problem of Asia Only?
Chapter 32. The Prevention of the Respiratory Syncytial Virus Infection in Infants
Chapter 33. The Management and Treatment of Acute Bronchiolitis in Infants
Chapter 34. A Practical, Pathophysiology-Based Approach to Severe Bronchiolitis
Chapter 35. Predictors of Clinical Deterioration in Bronchiolitis: A Guide to Decisions Concerning Hospitalization and Referrals to a Pediatric Intensive Care Unit
Volume 3
Chapter 36. Bayesian Coalescent Inference Demonstrates Differences in Evolutionary Dynamics among Norovirus GII Genotypes
Chapter 37. Considerations for Exposure and Dose-Response Assessment in Norovirus QMRA
Chapter 38. Solar Radiation and Photo-Fenton Systems: Novel Applications for Norovirus Disinfection in Water
Chapter 39. High Pressure Processing’s Potential to Inactivate Noroviruses and other Foodborne Viruses
Chapter 40. Aptamer: The Potential Application to Norovirus Research, Diagnosis, and Therapeutics
Chapter 41. The Journey Towards an Effective Norovirus Vaccine
Chapter 42. Impacts of West Nile Virus on the Yellow-Billed Magpie and Other Birds in California’s Central Valley
Chapter 43. Recombinant Envelope Domain Iii Protein of West Nile Virus: Recent Developments and Applications
Chapter 44. Multi-Species, Climate-Driven and Landscape-Based Cellular Difference Equation Model for West Nile Virus: Toward an Agent-Based Model of West Nile Virus Spread
Chapter 45. West Nile Virus Infection in Western Province of Zambia: Assessing the Contributing Factors
Chapter 46. Is North-Western Province of Zambia at Risk for West Nile Virus Infection?
Volume 4
Chapter 47. Control Strategies of Ebola Virus Disease in Bioinformatics Perspective
Chapter 48. Preventive and Control Measures of Ebola Viral Disease Outbreak: A Race against Time and Cultural Practices
Chapter 49. Modelling the Distribution and Spread of Ebola Disease in West Africa
Chapter 50. Controlling the Spread of the Ebola Virus Disease through the Prism of Human Rights and Medical Ethics
Chapter 51. The “Eboliticization” of Discourse: Online Legitimations on the Outbreak of Ebola Virus Disease (EVD) in West Africa
Chapter 52. Prophylaxis of Cancers from Human Papilloma Viruses (HPV’s)
Chapter 53. Bioinformatics as an Auxiliary Tool for the Treatment and Prevention of Human Papillomavirus Infection
Chapter 54. An Update in the Detection, Prevention, and Transformation Potential of Human Papillomaviruses (HPVs)
Chapter 55. Human Papilloma Virus-Related Oropharyngeal Cancer: An Update
Chapter 56. Noroviruses in Brazil
Chapter 57. Noroviruses in Italy
Chapter 58. Noroviruses in Dogs
Volume 5
Chapter 59. Foodborne Viruses
Chapter 60. Recent Virus Infectious Diseases in Magellanic Penguins (Spheniscus magellanicus) and Their Identified Agents
Chapter 61. Immunomodulation Mechanisms Developed by Bovine Viral Diarrhea Virus and its Role in the Establishment of the Bovine Respiratory Disease Complex
Chapter 62. Influenza Viruses as a Threat to Marine Mammals Populations
Chapter 63. Modulating Regulated Cell Death: The Virus way to Influence Cell Fate, Survive and Persist
Chapter 64. Systems for Rapidly Detecting and Treating Persons with Ebola Virus Disease — United States
Chapter 65. Epidemiological Aspects of Hepatitis C Virus Infection among Seekers of Serological Tests in Blood Bank in Pará, Brazilian Amazon
Chapter 66. Ecology of Avian Influenza Viruses in Siberia
Chapter 67. Epidemiology of Hepatitis B Virus Infection among Non-Injecting Drug Users in the State of Pará, Brazilian Amazon
Chapter 68. Hepatitis B Virus
Chapter 69. Hepatitis C Virus
Chapter 70. Characterization of Anti-Coxsackie Virus B3 Constituents of Scabiosa Arenaria Forssk by RP-HPLC-UV Method
Chapter 71. Studies on Inhibitors of Dengue Virus Protease
Chapter 72. Induced Resistance against Broad Bean True Mosaic Virus in Faba Bean Plants using Salicylic Acid
Volume 6
Chapter 73. Photothermal Therapy for Virus Infections
Chapter 74. Hepatitis B Virus Reactivation during Immunosuppressive Therapy
Chapter 75. Pediatrics and Human Immunodeficiency Virus
Chapter 76. Dengue Virus Infection: A Common Tropical Disease
Chapter 77. Nipah Virus: What Has Been Learned since the Discovery of This Deadly Virus Nearly Two Decades Ago?
Chapter 78. Various Virus Diseases of Papaya Plants Occurring in Different Countries
Chapter 79. Lactoferrin and Hepatitis C Virus: Flexible Fitting and Invasive Mechanism
Chapter 80. Survival of Wastewater Viruses in the Environment
Chapter 81. Yellow Fever in Brazil: Actions for Vaccination in the Years 2017 and 2018, Transmission of the Virus and Future Perspectives
Chapter 82. Adverse Effects of Oseltamivir in the Treatment of AH1N Virus Infections in Pediatric Populations
Chapter 83. Molecular Mechanism of Oseltamivir and Other Lead Compounds Towards Influenza a Virus Based on Proteomics and Transcriptomics Approaches
Chapter 84. Antiviral Treatment and Therapy against Avian Influenza Virus (H5N1)
Chapter 85. Coordination of Molecular Techniques and Advanced Bioinformatics Tools for Analyzing Viral Evolutionary Distance with an Emphasis on Foot-And-Mouth Disease Virus (FMDV) Serotype O
Chapter 86. Stress Management for Decreasing Recurrence of Herpes Simplex Virus Infection
Index